Robert Galemmo joins the Southern Research Institute as Senior Medicinal Chemist

Life Science Partner recruits former Senior Scientist at Elan Pharmaceuticals

 Life Science Partner announces the recruitment of Robert Galemmo, PhD, to the Southern Research Institute in Birmingham, Alabama.  Southern Research Institute is an independent, not-for-profit center for scientific research  organization with a focus on the discovery and advancement of new, small-molecule therapeutics from the design stage to the clinic, Southern Research Institute’s Drug Discovery Research Division has accomplished innovative research in the areas of cancer, infectious disease and neuroscience.

At Elan Pharmaceuticals, Galemmo oversaw the leadership of two chemistry efforts in the discovery of highly selective CNS penetrant kinase inhibitors for Parkinson’s disease.  Previously, he served as Senior Director and Head of Chemistry at Neuromed Pharmaceuticals, a Vancouver-based biotechnology company focused on calcium ion channel inhibitors.

“Galemmo is a talented medicinal chemist and experienced manager of diverse scientific teams,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “His broad therapeutic area experience will serve the Institute well, as it builds upon its considerable success in drug discovery.”

Galemmo earned his Bachelor of Science Degree and PhD in Organic Chemistry from Ohio State University.